INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Provided By PR Newswire
Last update: Nov 14, 2024
PLYMOUTH MEETING, Pa., Nov. 14, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results for the third quarter of 2024 and provided an update on recent company developments.
Read more at prnewswire.com
